Business

OTC Markets Group Appoints JP Chan to Spearhead Asia-Pacific Growth in Hong Kong

By David Wong
|
Published: 2026-05-05 15:59

OTC Markets Group has announced the appointment of JP Chan as the new head of Asia-Pacific operations, focusing on expanding its presence in Hong Kong. This strategic move aims to enhance the company's engagement with Asian markets and improve access for local companies to U.S. investors.

OTC Markets Group Expands Leadership in Asia-Pacific

OTC Markets Group, a leading financial market providing price and liquidity information for over-the-counter (OTC) securities, has made a significant move to bolster its operations in the Asia-Pacific region by appointing JP Chan as the new head of its Hong Kong office. This strategic appointment is expected to enhance the company’s growth trajectory in one of the world’s most dynamic financial hubs.

JP Chan's Extensive Experience

JP Chan brings a wealth of experience to the role, having spent over two decades in various leadership positions across the financial services industry. His extensive background includes significant roles in investment banking, capital markets, and corporate finance, which positions him well to lead OTC Markets Group’s initiatives in the region. Chan has previously worked with notable financial institutions, where he has been instrumental in developing market strategies and fostering relationships with key stakeholders.

Focus on Hong Kong's Financial Landscape

Hong Kong has long been recognized as a pivotal financial center in Asia, serving as a gateway for international investors seeking to tap into the vast opportunities presented by the region. With the increasing interest from U.S. investors in Asian markets, OTC Markets Group aims to leverage Chan’s expertise to enhance its service offerings and provide better access for local companies looking to attract investment from the United States.

Strategic Goals and Initiatives

Under Chan's leadership, OTC Markets Group plans to implement a series of strategic initiatives aimed at increasing awareness and understanding of the OTC market among Asian companies. This includes educational outreach programs, workshops, and seminars designed to inform potential issuers about the benefits of listing on OTC Markets. The company also aims to create a more streamlined process for Asian companies to access U.S. capital markets, thereby fostering greater cross-border investment.

Enhancing Market Connectivity

Chan stated, “I am excited to take on this new role and look forward to working with our team to enhance the connectivity between Asian companies and U.S. investors. The Asia-Pacific region is ripe with opportunities, and I believe that OTC Markets Group can play a crucial role in facilitating these connections.” His vision aligns with the company’s broader goal of becoming the premier marketplace for OTC securities in the Asia-Pacific region.

Impact on Local Companies

The appointment comes at a time when many Hong Kong-based companies are seeking alternative funding sources amid changing market conditions. By providing a platform that connects these companies with U.S. investors, OTC Markets Group aims to empower local businesses to expand their reach and enhance their financial prospects. This is particularly important as many companies are looking to diversify their funding sources in light of increasing global competition.

Conclusion

As JP Chan steps into his new role, the financial community in Hong Kong and beyond will be watching closely to see how OTC Markets Group executes its growth strategy in the Asia-Pacific region. With a strong focus on education, accessibility, and market connectivity, the company is poised to make a significant impact on the local financial landscape, ultimately benefiting both investors and issuers alike.